Diagnosing diseases like cancer, infections and autoimmune conditions often depends on examining tissue samples under a microscope. This process can be slow owing to the many time-consuming steps involved in preparing tissue samples for observation, i.e. to enable visible contrast between cancerous and non-cancerous cells. Furthermore, the process can be subjective, with doctors sometimes reaching different conclusions, leading to more tests or, in the worst case, misdiagnosis. In this context, the EIC-funded OPTIPATH project offers a solution with a groundbreaking approach to tissue analysis. Using advanced optical chip-based technology with machine learning, it aims to provide fast, accurate 3D imaging of unprepared tissue samples. Invisible properties of light will be harnessed to give access to information currently unavailable to practitioners.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.eic-optipath.eu/
- Keywords
- Henan UM optics ltd.
Optipath Questions
Optipath's website is http://www.eic-optipath.eu/
Optipath's LinkedIn profile is https://www.linkedin.com/company/eicoptipath
Optipath's industry is
Biotechnology Research
Optipath's top competitors are
Cc-Norchip,
Pathy,
Nil Technology,
Henan Um Optics Ltd,
Danish Optical Society (Dops),
Ntnu Nanolab,
The Ntnu Alt Protein Project,
S3 Medical,
Eduhouse As,
Spectrogon Us Inc.
Optipath's categories are Biotechnology Research
